Celegene, CES and Everything Else You Need to Know Monday in Under 60 Seconds

Are you ready to start the week? Here's what needs to be on your radar.
Publish date:

Here's everything you need to know before Monday's opening bell: 

    Celgene agreed to buy Impact Biomedicines for as much as $7 billion. 

    Apple has been urged to take action to curb growing smartphone addiction among children. 

    Driverless cars steal the show at the first day of CES in Las Vegas.

    Dunkin' will roll out its streamlined menu at all U.S. locations by mid-March.

    U.S. stock futures suggest Wall Street's strong start to the new year will continue.

    Watch More with TheStreet: